The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study

Ackerman, 1998, Bodyweight gain induced by psychotropic drugs: incidence, mechanisms and management, CNS Drugs, 9, 135, 10.2165/00023210-199809020-00005 Allison, 1999, Antipsychotic-induced weight gain: a comprehensive research synthesis, Am. J. Psychiatry, 156, 1686, 10.1176/ajp.156.11.1686 Basson, 2001, Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone, J. Clin. Psychiatry, 62, 231, 10.4088/JCP.v62n0404 Bowden, 2005, A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder, J. Clin. Psychiatry, 66, 111, 10.4088/JCP.v66n0116 Cerhan, 2014, A pooled analysis of waist circumference and mortality in 650,000 adults, Mayo Clin. Proc., 89, 335, 10.1016/j.mayocp.2013.11.011 De Hert, 2011, Metabolic and cardiovascular adverse effects associated with antipsychotic drugs, Nat. Rev. Endocrinol., 8, 114, 10.1038/nrendo.2011.156 Dent, 2012, Changes in body weight and psychotropic drugs: a systematic synthesis of the literature, PLoS One, 7, e36889, 10.1371/journal.pone.0036889 Fagiolini, 2005, Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians, Bipolar Disord., 7, 424, 10.1111/j.1399-5618.2005.00234.x Fang, F., Wang, Z., Wu, R., Calabrese, J.R., Gao, K., 2017. Is there a 'weight neutral' second-generation antipsychotic for bipolar disorder? Expert Rev Neurother. 17, 407–418. Geddes, 2004, Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials, Am. J. Psychiatry, 161, 217, 10.1176/appi.ajp.161.2.217 Geddes, 2013, Treatment of bipolar disorder, Lancet, 381, 1672, 10.1016/S0140-6736(13)60857-0 Goodwin, 2016, Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology, J. Psychopharmacol, 30, 495, 10.1177/0269881116636545 Grunze, 2013, The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder, World J. Biol. Psychiatry, 14, 154, 10.3109/15622975.2013.770551 Hayes, 2016, Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study, PLoS Med, 13, 10.1371/journal.pmed.1002058 Henderson, 2015, Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses, Lancet Psychiatry, 2, 452, 10.1016/S2215-0366(15)00115-7 Javaras, 2008, Co-occurrence of binge eating disorder with psychiatric and medical disorders, J. Clin. Psychiatry, 69, 266, 10.4088/JCP.v69n0213 Keck, 2003, Bipolar disorder, obesity, and pharmacotherapy-associated weight gain, J. Clin. Psychiatry, 64, 1426, 10.4088/JCP.v64n1205 Kemp, 2014, General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial, Acta Psychiatr. Scand., 129, 24, 10.1111/acps.12101 Kluge, 2007, Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study, J. Clin. Psychopharmacol., 27, 662, 10.1097/jcp.0b013e31815a8872 Lipkovich, 2006, Early predictors of substantial weight gain in bipolar patients treated with olanzapine, J. Clin. Psychopharmacol., 26, 316, 10.1097/01.jcp.0000219916.88810.1c McElroy, 2011, Prevalence and correlates of eating disorders in 875 patients with bipolar disorder, J. Affect. Disord., 128, 191, 10.1016/j.jad.2010.06.037 McElroy, 2016, Clinical features of bipolar spectrum with binge eating behaviour, J. Affect. Disord., 201, 95, 10.1016/j.jad.2016.05.003 Meltzer, 2011, A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation, J. Clin. Psychiatry, 72, 1602, 10.4088/JCP.10m05997 Nierenberg, 2016, Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder, J. Clin. Psychiatry, 77, 90, 10.4088/JCP.14m09349 Nierenberg, 2014, Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder, Clin. Trials, 11, 114, 10.1177/1740774513512184 Perron, 2009, Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions, J. Clin. Psychiatry, 70, 1407, 10.4088/JCP.08m04586yel Schwartz, 2004, Psychiatric medication-induced obesity: treatment options, Obesity Rev., 5, 115, 10.1111/j.1467-789X.2004.00139.x Serretti, 2010, Antidepressants and body weight: a comprehensive review and meta-analysis, J. Clin. Psychiatry, 71, 1259, 10.4088/JCP.09r05346blu Simon, 2009, Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review, J. Clin. Psychiatry, 70, 1041, 10.4088/JCP.08r04392 Spearing, 1997, Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP, Psychiatry Res., 73, 159, 10.1016/S0165-1781(97)00123-6 Sylvia, 2015, Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE), Bipolar Disord., 17, 212, 10.1111/bdi.12243 Torrent, 2008, Weight gain in bipolar disorder: pharmacological treatment as a contributing factor, Acta Psychiatr. Scand., 118, 4, 10.1111/j.1600-0447.2008.01204.x Valencak, 2017, Sex matters: the effects of biological sex on adipose tissue biology and energy metabolism, Redox Biol., 12, 806, 10.1016/j.redox.2017.04.012 Vieta, 2011, Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials, Int. J. Neuropsychopharmacol., 14, 1029, 10.1017/S1461145711000885 Yatham, 2013, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disord, 14, 1, 10.1111/bdi.12025 Young, 2010, A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I), J. Clin. Psychiatry, 71, 150, 10.4088/JCP.08m04995gre